WHO ICTRP trial
Study of Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO…
NCT04550572 · NIH Clinical Trials · Not recruiting
Key facts
| Trial ID | NCT04550572 |
|---|---|
| Public title | Study of Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency |
| Scientific title | Study of Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency |
| Primary sponsor | Medicure |
| Registry | NIH Clinical Trials |
| Recruitment status | Not recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Conditions | Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency |
| Interventions | Drug: Pyridoxal 5'-Phosphate |
| Registration date | Sep 9, 2020 |
| Target size | 10 |
| Secondary IDs | 16002 |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: